| Mr Robert Bobek Arashahi, MD | |
|
5652 E Baseline Rd, Mesa, AZ 85206-4713 | |
| (480) 477-7166 | |
| Not Available |
| Full Name | Mr Robert Bobek Arashahi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 5652 E Baseline Rd, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003995457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 43965 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Dignity Health Arizona General Hospital | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pioneer Hospitalists, Pllc | 0941290290 | 51 |
News Archive
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
In work that aims to protect soldiers from biological and chemical threats, a team of Lawrence Livermore National Laboratory scientists has created a material that is highly breathable yet protective from biological agents.
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
› Verified 9 days ago
| Entity Name | American Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609869908 PECOS PAC ID: 3577467463 Enrollment ID: O20031121000688 |
News Archive
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
In work that aims to protect soldiers from biological and chemical threats, a team of Lawrence Livermore National Laboratory scientists has created a material that is highly breathable yet protective from biological agents.
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
› Verified 9 days ago
| Entity Name | Pioneer Hospitalists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033177316 PECOS PAC ID: 0941290290 Enrollment ID: O20040517001550 |
News Archive
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
In work that aims to protect soldiers from biological and chemical threats, a team of Lawrence Livermore National Laboratory scientists has created a material that is highly breathable yet protective from biological agents.
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
› Verified 9 days ago
| Entity Name | Cogent Healthcare Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568758266 PECOS PAC ID: 0648441006 Enrollment ID: O20110915000843 |
News Archive
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
In work that aims to protect soldiers from biological and chemical threats, a team of Lawrence Livermore National Laboratory scientists has created a material that is highly breathable yet protective from biological agents.
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
› Verified 9 days ago
| Entity Name | 4c Medical Group Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558654384 PECOS PAC ID: 2769653641 Enrollment ID: O20110926000641 |
News Archive
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
In work that aims to protect soldiers from biological and chemical threats, a team of Lawrence Livermore National Laboratory scientists has created a material that is highly breathable yet protective from biological agents.
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Bobek Arashahi, MD 67 S Higley Rd, Suite 103-509, Gilbert, AZ 85296-1166 Ph: (480) 550-1119 | Mr Robert Bobek Arashahi, MD 5652 E Baseline Rd, Mesa, AZ 85206-4713 Ph: (480) 477-7166 |
News Archive
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
New research from New Zealand has found that over-eating rather than lack of physical activity, is why Kiwis are pilling on the excess kilos.
In work that aims to protect soldiers from biological and chemical threats, a team of Lawrence Livermore National Laboratory scientists has created a material that is highly breathable yet protective from biological agents.
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia Foundation (CCAF) grant.
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin's B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
› Verified 9 days ago
Dr. Emmanuel A Bayongan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert P Tully, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |